Literature DB >> 10777590

FHX, a novel fork head factor with a dual DNA binding specificity.

C Pérez-Sánchez1, M A Gómez-Ferrería, C A de La Fuente, B Granadino, G Velasco, A Esteban-Gamboa, J Rey-Campos.   

Abstract

The HNF3/fork head family includes a large number of transcription factors that share a structurally related DNA binding domain. Fork head factors have been shown to play important roles both during development and in the adult. We now describe the cloning of a novel mammalian fork head factor that we have named FHX (fork head homologous X (FHX), which is expressed in many adult tissues. In the embryo, FHX expression showed a very early onset during the cleavage stages of preimplantation development. Polymerase chain reaction-assisted site selection experiments showed that FHX bound DNA with a dual sequence specificity. Sites recognized by FHX could be classified into two different types according to their sequences. Binding of FHX to sequences of each type appeared to occur independently. Our data suggest that either different regions of the fork head domain or different molecular forms of this domain could be involved in binding of FHX to each type of site. In transfection assays, FHX was capable of activating transcription from promoters containing FHX sites of either type.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777590     DOI: 10.1074/jbc.275.17.12909

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  The multiassembly problem: reconstructing multiple transcript isoforms from EST fragment mixtures.

Authors:  Yi Xing; Alissa Resch; Christopher Lee
Journal:  Genome Res       Date:  2004-02-12       Impact factor: 9.043

2.  Identifying tissue-selective transcription factor binding sites in vertebrate promoters.

Authors:  Andrew D Smith; Pavel Sumazin; Michael Q Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

3.  FOXJ2 expression in rat spinal cord after injury and its role in inflammation.

Authors:  Xiang Chen; Xingjian Cao; Guohua Tao; Zhaoming Cao; Shuo Wang; Feng Zhou; Wei Xie; Peng Zhao; Zheping Zhang; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2012-01-13       Impact factor: 3.444

4.  The forkhead transcription factor FoxI1 remains bound to condensed mitotic chromosomes and stably remodels chromatin structure.

Authors:  Jizhou Yan; Lisha Xu; Gregory Crawford; Zenfeng Wang; Shawn M Burgess
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors.

Authors:  Thomas W Sturgill; Paul B Stoddard; Steven M Cohn; Marty W Mayo
Journal:  Mol Cancer       Date:  2010-05-11       Impact factor: 27.401

6.  Biological effects of FoxJ2 over-expression.

Authors:  F Martín-de-Lara; P Sánchez-Aparicio; Carmen Arias de la Fuente; J Rey-Campos
Journal:  Transgenic Res       Date:  2008-08-26       Impact factor: 2.788

7.  ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line.

Authors:  Yideng Liang; Haibing Jiang; Tamara Ratovitski; Chunfa Jie; Masayuki Nakamura; Ricky R Hirschhorn; Xiaofang Wang; Wanli W Smith; Tsonwin Hai; Michelle A Poirier; Christopher A Ross
Journal:  Brain Res       Date:  2009-06-24       Impact factor: 3.252

8.  Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men.

Authors:  Joke Beuten; Jonathan A L Gelfond; Margarita L Martinez-Fierro; Korri S Weldon; AnaLisa C Crandall; Augusto Rojas-Martinez; Ian M Thompson; Robin J Leach
Journal:  Carcinogenesis       Date:  2009-06-15       Impact factor: 4.944

9.  Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.

Authors:  Takaki Hiwasa; Hao Wang; Ken-Ichiro Goto; Seiichiro Mine; Toshio Machida; Eiichi Kobayashi; Yoichi Yoshida; Akihiko Adachi; Tomoo Matsutani; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Mitoshi Kunimatsu; Ikuo Kamitsukasa; Masahiro Mori; Kazuo Sugimoto; Akiyuki Uzawa; Mayumi Muto; Satoshi Kuwabara; Yoshio Kobayashi; Mikiko Ohno; Eiichiro Nishi; Akiko Hattori; Masashi Yamamoto; Yoshiro Maezawa; Kazuki Kobayashi; Ryoichi Ishibashi; Minoru Takemoto; Koutaro Yokote; Hirotaka Takizawa; Takashi Kishimoto; Kazuyuki Matsushita; Sohei Kobayashi; Fumio Nomura; Takahiro Arasawa; Akiko Kagaya; Tetsuro Maruyama; Hisahiro Matsubara; Minako Tomiita; Shinsaku Hamanaka; Yushi Imai; Tomoo Nakagawa; Naoya Kato; Jiro Terada; Takuma Matsumura; Yusuke Katsumata; Akira Naito; Nobuhiro Tanabe; Seiichiro Sakao; Koichiro Tatsumi; Masaaki Ito; Fumiaki Shiratori; Makoto Sumazaki; Satoshi Yajima; Hideaki Shimada; Mikako Shirouzu; Shigeyuki Yokoyama; Takashi Kudo; Hirofumi Doi; Katsuro Iwase; Hiromi Ashino; Shu-Yang Li; Masaaki Kubota; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Yasuo Iwadate
Journal:  BMC Med       Date:  2021-06-09       Impact factor: 8.775

10.  Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines.

Authors:  Richa Dubey; Ravindresh Chhabra; Neeru Saini
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.